Free Virtual Consultations. Corona Virus Related Cases Click Here.

Pedestrian Killed in Crash on Tank Farm Road

Victim Hit by Car in Fatal San Luis Obispo Accident


San Luis Obispo, CA (February 11, 2020) – One person was killed in a pedestrian crash in San Luis Obispo. The fatal accident occurred on the evening of February 11 on Tank Farm Road.

A pedestrian was hit by a car on Tank Farm Road, near Higuera Street. Emergency crews found the pedestrian down in the road. The victim died at the accident scene. The road was shut down for several hours.

Our heartfelt condolences go out to the friends and loved ones of the victim.

#San Luis Obispo


November 18, 2019

Juana de Jesus Rodriguez Killed in Crash on Nordhoff Street

Woman Hit by Car in Fatal Hit and Run Accident in Panorama City...

October 31, 2019

1 Injured in Multi-Vehicle Crash on Highway 4 Near Railroad Avenue

3 Vehicles Involved in Pittsburg Accident...

November 14, 2019

Man Killed in Crash on Laguna Boulevard

Driver’s Side of Pickup Damaged in Fatal Elk Grove Accident...

Free Police Report Request

We offer free consultation. No office visit required, we will get back to you within 24 hours.

  • This field is for validation purposes and should be left unchanged.

What can we do for you?

  • Answer your legal question.
  • Provide a Free Case Evaluation.
  • Schedule an appointment.

Why Choose Us?

  • Available 24/7
  • Trusted Since 1990
  • Local to You
  • Recovered $350,000,000
  • 5 Star Reviews
  • Free Case Evaluation
  • VIP Service
  • No Win, No Fee

Latest Law Post

May 22, 2020

Johnson & Johnson Discontinues Talc-Based Baby Powder

baby powder new Johnson & Johnson discontinued its talc-based baby powders in the United States and Canada because thousands of lawsuits claiming it was contaminated with asbestos created a sales decline.

May 18, 2020

FDA Issues Warnings To Two Manufacturers Of Breast Implants

The U.S. Food and Drug Administration (FDA) just issued warning letters to two manufacturers of breast implants for failing to comply with regulatory requirements. The FDA sent a warning letter to Allergan for failure to comply with requirements to conduct post-approval studies assessing the risks and long-term safety of two separate breast implant models. Both breast implant models were voluntarily recalled last year. The FDA also sent a warning letter to Ideal Implant Incorporated. That letter was sent for failing to comply with adverse event reporting requirements and current good manufacturing practice requirements. The letter was prompted by an inspection which was conducted earlier in 2020.